Citation only via Europe PMC

A New Frontier: Partial Cellular Reprogramming in Plastic Surgery.

Mahmoud AA, Fijany A, Copeland-Halperin L, Wong G.

Plastic and reconstructive surgery · 2026

Epigenetic alterations Partial reprogramming (OSK) Human

Abstract

Partial cellular reprogramming employs Yamanaka factors to shift aging cells toward a younger epigenetic state without compromising cellular identity. Over two decades, this Nobel Prize winning breakthrough has advanced from the bench to a first in-human trial in 2026 for optic neuropathy and glaucoma. Here, we outline the foundation of partial cellular reprogramming and delineate its intersection with our field. Defined by innovation, plastic surgery can shape how partial reprogramming is applied in what may prove to be a transformative chapter for our specialty.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: Europe PMC
DOI: 10.1097/prs.0000000000013549
Canonical: link ↗
Fetched: 2026-10-22 MST

Cite this

APA

AA, M., A, F., L, C., & G., W. (2026). A New Frontier: Partial Cellular Reprogramming in Plastic Surgery. <em>Plastic and reconstructive surgery</em>. https://doi.org/10.1097/prs.0000000000013549

Vancouver

AA M, A F, L C, G. W. A New Frontier: Partial Cellular Reprogramming in Plastic Surgery. Plastic and reconstructive surgery. 2026. doi:10.1097/prs.0000000000013549.

BibTeX

@article{mahmoud2026ANewFr, title = {A New Frontier: Partial Cellular Reprogramming in Plastic Surgery.}, author = {Mahmoud AA and Fijany A and Copeland-Halperin L and Wong G.}, journal = {Plastic and reconstructive surgery}, year = {2026}, doi = {10.1097/prs.0000000000013549}, }